Table 3 Results are presented as the means ± SEMs. *: control vs. DEPO, (“one-way ANOVA”, p < 0.01), #: DEPO + LPS vs. LPS, (“one-way ANOVA”, p < 0.001), ☆: DEPO + LPS vs. LPS, (“one-way ANOVA”, p < 0.05), ♦: control vs. LPS, (“one-way ANOVA”, p < 0.001)
From: Darbepoetin alpha has an anxiolytic and anti-neuroinflammatory effect in male rats
GROUPS | Control | DEPO | LPS | DEPO + LPS |
|---|---|---|---|---|
HB (g/dl) | 17,85 ± 0,72 | 21,85 ± 0,71 * | 16,26 ± 0,81 | 20,61 ± 1,02# |
HCT (%) | 54,38 ± 1,92 | 67,88 ± 1,63 * | 50,88 ± 2,62 | 60,50 ± 2,33# |
Glucose (mg/dl) | 106 ± 4,21 | 105 ± 4,73 | 114 ± 3,76 | 105,8 ± 5,11 |
Weight loss (g) | 0,62 ± 0,26 | 0,50 ± 0,80 | 34 ± 4,06♦ | 17,25 ± 1,74# |
Weight loss % | 0,23 ± 0,09 | 0,25 ± 0,09 | 9,77 ± 0,90♦ | 4,99 ± 0,43# |
Loss of posture latency (sec) | 81,13 ± 4,65 | 90,13 ± 5,24 | 43,13 ± 3,19♦ | 65,13 ± 6,84☆ |
Deep anesthesia latency (sec) | 170, 4 ± 6,23 | 264,3 ± 21, 86 * | 81,13 ± 6,69♦ | 163,9 ± 17,61☆ |